OrthoPediatrics announced that it completed the acquisition of ApiFix for $2 million in cash and nearly 1 million shares of OrthoPediatrics’ common stock. Warsaw, Ind.–based OrthoPediatrics’ purchase includes the cash, 934,768 shares of common stock and milestone payments and an earnout over four years. Israel- and Boston-based ApiFix develops a minimally invasive deformity correction (MID-C) […]
Apifix
FDA approves ApiFix’s MID-C scoliosis device
ApiFix said today that it won a humanitarian device exemption from the FDA for its MID-C implant for treating pediatric scoliosis. The Boston-area company said the minimally invasive deformity correction device’s August 23 approval covers patients with progressive adolescent idiopathic scoliosis. “FDA approval of ApiFix’s MID-C system is a significant achievement for our company,” CEO […]
5 pediatric orthopedic devices you need to know
The National Capital Consortium for Pediatric Device Innovation recently recognized five pediatric orthopedic devices that could improve scoliosis treatment, clubfoot assessment and surgical imaging. The five winners of the NCC-PDI’s “Make Your Medical Device Pitch for Kids!” competition — announced May 1 — will each receive $50,000 in grant funding and access to the consortium’s […]
7 medtech stories we missed this week: August 11, 2017
From Xtant Medical’s 510(k) extension to Varian Medical’s distribution deal, here are seven medtech stories we missed this week but thought were still worth a mention. 1. FDA extends Xtant Medical’s 510(k) for Calix C spinal implant Xtant Medical announced in an Aug. 9 press release that the FDA has cleared its product line extensions […]
7 medtech stories we missed this week: July 21, 2017
From Second Sight’s South Korean market entry to Sanuwave’s Indonesian distribution deal, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Second Sight enters South Korea market Second Sight announced in a July 5 press release that it has entered the market in South Korea with the implantation […]
B. Braun’s Aesculap puts nearly $3m into ApiFix
B. Braun’s Aesculap division today invested $2.8 million into ApiFix’s $5 million Series B financing round to help support ApiFix’s minimally invasive, non-fusion spinal implant system designed to treat adolescent idiopathic scoliosis. The ApiFix device, which won CE Mark clearance for use in the European Union in 2012, is designed to correct adolescent idiopathic scoliosis […]
ApiFix expands its European footprint
ApiFix said Wednesday it is opening new treatment centers in Italy, France and the Netherlands, which will use the company’s ApiFix minimally invasive system for adolescent idiopathic scoliosis. The system, which has CE Mark clearance for the European Union, has been used to treat over 50 patients since approval, according to the Israel-based company. “Scoliosis surgery is […]
